Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis
Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people i...
Main Authors: | O. S. Mikhaylova, A. V. Krikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2022-07-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/693 |
Similar Items
-
PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01) -
PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION
by: S. G. Gorokhova, et al.
Published: (2012-08-01) -
Pharmacoeconomic analysis of ischemic stroke therapy in patients with arterial hypertension
by: Mashin V.V., et al.
Published: (2010-09-01) -
Development conceptual of pharmacoeconomic model of technology for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko
Published: (2022-12-01) -
Scientific substantiation of the concept of pharmacoeconomic analysis of technologies for early diagnosis and pharmacotherapy of pulmonary arterial hypertension
by: I. S. Datsenko, et al.
Published: (2022-10-01)